New biomaterials can contribute to drug delivery by enabling spatiotemporal control of drug release, overcoming biological barriers on multiple levels, and providing additional functions to enhance the precision of the delivery. Significant efforts have been made to improve the efficacy and safety of anticancer medicine in the last few decades. Lessons learned from past efforts are now applied to address fundamental challenges in drug delivery and expanded to new opportunities in emerging therapeutic fields such as gene editing and immunotherapy. This symposium will invite experts in the field of controlled drug delivery, nanomedicine, biomaterials, cell therapeutics, and global health to discuss fundamental issues, innovation, and new opportunities in drug delivery.

We welcome abstract submissions on a broad range of topics relevant to local and systemic drug delivery as well as imaging and diagnostics, including drug-device combination products; nanomedicine for novel applications such as infectious diseases and neurological disorders; drug/vaccine delivery for enhancing global health; functional biomaterials for immunotherapy; cell-based therapy; machine learning in the design of drug and carrier. We will actively promote discussions on challenges in clinical translation of novel drug delivery systems and new combinations of drug delivery and emerging therapeutic modalities.

biological biomaterial biomedical biomimetic DNA machine learning organic polymer protein tissue